Form 4 for GILD Gilead Sciences
Accepted 2026-01-29 00:00:00 ET · period of report 2026-01-28 · accession 0001638643-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-29 | 2026-01-28 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $139.89 | -10.0K | 561.7K | -2% | -$1.40M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-28 | S | D | 4,968 | $140.24 | 556,698 | D | — | — | (F3) Sale prices for the transactions reported range from $140.00 to $140.57. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| 2 | Common | Common Stock | 2026-01-28 | S | D | 5,032 | $139.54 | 561,666 | D | — | — | (F2) Sale prices for the transactions reported range from $138.99 to $139.97. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |